World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
21576
World Ranking
14775
National Ranking
7466

Kenneth A. Krohn publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Kenneth A. Krohn sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 343 publications — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Kenneth A. Krohn D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Kenneth A. Krohn sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Kenneth A. Krohn is affiliated with Oregon Health & Science University in the United States. Their research spans multiple areas within medicine and biochemistry, genetics, and molecular biology, with a focus on molecular biology, radiology, nuclear medicine and imaging, pulmonary and respiratory medicine, cancer research, and oncology.

The scientist's recent publications include studies centered on medical imaging techniques and applications, histone deacetylase inhibitors research, advanced breast cancer therapies, protein degradation and inhibitors, radiomics and machine learning in medical imaging, cancer hypoxia, metabolism, and breast cancer treatment studies.

  • "18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2− Metastatic Breast Cancer" (2020), published in Journal of Nuclear Medicine
  • "Assessment of the Prognostic Value of Radiomic Features in 18F-FMISO PET Imaging of Hypoxia in Postsurgery Brain Cancer Patients: Secondary Analysis of Imaging Data from a Single-Center Study and the Multicenter ACRIN 6684 Trial" (2020), published in Tomography
  • "18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study" (2021), published in Breast Cancer Research
  • "[18F]-fluoromisonidazole (FMISO) PET/MRI hypoxic fraction distinguishes neuroinflammatory pseudoprogression from recurrent glioblastoma in patients treated with pembrolizumab" (2022), published in Neuro-Oncology Practice
  • "Concepts for design and analysis of receptor radiopharmaceuticals: The Receptor-Binding Radiotracers series of meetings provided the foundation" (2020), published in Nuclear Medicine and Biology

Frequent coauthors who have collaborated with Kenneth A. Krohn include Jeanne Link, David A. Mankoff, Lanell M. Peterson, Brenda F. Kurland, and Jennifer M. Specht.

Publication venues where their work has appeared include:

  • Journal of Nuclear Medicine
  • Tomography
  • Breast Cancer Research
  • Neuro-Oncology Practice
  • Nuclear Medicine and Biology

The primary fields of study for the scientist are Medicine and Biochemistry, Genetics and Molecular Biology. Their research touches specific subfields such as Molecular Biology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Cancer Research, and Oncology.

Main topics of their work encompass:

  • Medical Imaging Techniques and Applications
  • Histone Deacetylase Inhibitors Research
  • Advanced Breast Cancer Therapies
  • Protein Degradation and Inhibitors
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer, Hypoxia, and Metabolism
  • Breast Cancer Treatment Studies

Best Publications

  • Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: A pretherapy study of 37 patients

    Janet S. Rasey;Wui Jin Koh;Margaret L. Evans;Lanell M. Peterson

  • Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy

    Jeffrey M. Arbeit;J. Martin Brown;K. S.Clifford Chao;J. Donald Chapman

  • Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole.

    Wui Jin Koh;Janet S. Rasey;Margaret L. Evans;John R. Grierson

  • Molecular imaging of hypoxia.

    Kenneth A. Krohn;Jeanne M. Link;Ralph P. Mason

  • Quantitative Fluoroestradiol Positron Emission Tomography Imaging Predicts Response to Endocrine Treatment in Breast Cancer

    Hannah M. Linden;Svetlana A. Stekhova;Jeanne M. Link;Julie R. Gralow

  • Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.

    Joseph G. Rajendran;David A. Mankoff;Finbarr O'Sullivan;Lanell M. Peterson

  • Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer

    Joseph G. Rajendran;David L. Schwartz;David L. Schwartz;Janet O'Sullivan;Lanell M. Peterson

  • Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography

    Wui Jin Koh;Kenneth S. Bergman;Janet S. Rasey;Lanell M. Peterson

  • Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody.

    O W Press;J F Eary;C C Badger;P J Martin

  • Imaging oxygenation of human tumours

    Anwar R Padhani;Kenneth A. Krohn;Jason S Lewis;Markus L Alber

  • Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.

    S M Larson;J A Carrasquillo;K A Krohn;J P Brown

  • Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival.

    Alexander M. Spence;Mark Muzi;Kristin R. Swanson;Finbarr O'Sullivan

  • [(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression.

    J. G. Rajendran;D. C. Wilson;E. U. Conrad;L. M. Peterson

  • Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and 18F-Fluoroestradiol

    Lanell M. Peterson;David A. Mankoff;Thomas Lawton;Kevin Yagle

  • FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.

    David L. Schwartz;Eric Ford;Joseph Rajendran;Bevan Yueh

  • Radiolabeled fluoromisonidazole as an imaging agent for tumor hypoxia

    Janet S. Rasey;Wui Jin Koh;John R. Grierson;Zdenka Grunbaum

  • The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development

    Gary J. Kelloff;Kenneth A. Krohn;Steven M. Larson;Ralph Weissleder

  • FDG-PET prediction of head and neck squamous cell cancer outcomes

    David L. Schwartz;David L. Schwartz;Joseph Rajendran;Bevan Yueh;Marc D. Coltrera

  • Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells

    Janet S. Rasey;Zdenka Grunbaum;Sara Magee;Norma J. Nelson

  • Molecular Imaging of Hypoxia

    Satish K. Chitneni;Gregory M. Palmer;Michael R. Zalutsky;Mark W. Dewhirst

Frequent Co-Authors

David A. Mankoff
David A. Mankoff University of Pennsylvania
Paul E. Kinahan
Paul E. Kinahan University of Washington
Oliver W. Press
Oliver W. Press University of Washington
Todd L. Richards
Todd L. Richards University of Washington
Irwin D. Bernstein
Irwin D. Bernstein Fred Hutchinson Cancer Research Center
Karl Erik Hellström
Karl Erik Hellström University of Washington
Ingegerd Hellström
Ingegerd Hellström University of Washington
Steven M. Larson
Steven M. Larson Memorial Sloan Kettering Cancer Center
Frederick R. Appelbaum
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center
Michael J. Welch
Michael J. Welch Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and related online degrees can open up various career pathways in healthcare. For those who are already registered nurses, pursuing a BSN is more affordable than ever, thanks to cheap rn to bsn programs offered by many universities. These flexible options make it easier to advance your qualifications while balancing work and personal commitments.

If you don’t have a nursing background but want to enter the field quickly, direct entry msn programs for non-nurses online offer a fast-track route to becoming a qualified nurse. These accelerated programs are designed to get you into the workforce sooner.

Prospective students interested in nursing but concerned about competitiveness may benefit from learning whats the easiest nursing program to get into? to maximize their chances of acceptance.

For those seeking non-clinical careers in healthcare, medical billing and coding is a popular choice. Many top schools offer online programs with financial assistance. Check out these medical billing and coding financial aid opportunities to start your journey.

Best Scientists Citing Kenneth A. Krohn

Trending Scientists

Recently Published Articles